LIMG
LIMITATION OF GOODS RECEIVED FROM IB
05/28/2026
Back to search
Official data from USPTO
BOND PRIME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BOND PRIME
ST13
US500000079378815Class
5, 9, 10, 42
Filing
79378815
Registration
8268333
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
05/29/2026
Trademark type
Word
Nice classes
5, 9, 10, 42
Filing date
08/17/2023
Registration date
05/26/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/26/2026
Last transaction
05/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
82
Owner location
AU
Examiner
LAWRENCE, SUSAN KASTRINER
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Leica Biosystems Melbourne Pty Ltd
Representatives
ALEXIS P. GRILLI NIXON PEABODY LLP
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical and veterinary preparations namely reagents for medical and diagnostic purposes reagents for veterinary purposes; diagnostic preparation for medical use; antibody reagents used for the detection of antigens in cells and tissue for medical purposes; chemical reagents and diagnostic preparations for medical and veterinary purposes; medical diagnostic reagents; clinical medical reagents; medical diagnostic reagents for immuno-histochemistry detection and in situ-hybridisation detection; diagnostic preparations in the nature of in situ-hybridisation probes for medical and veterinary purposes; diagnostic preparations in the nature of epitope retrieval solutions; enzymes and enzyme preparations for medical and diagnostic purposes; diagnostic preparations in the nature of diagnostic histological dye and stain solutions for medical purposes; dewaxing and wash buffers used with the aforementioned preparations for use in disease testing; diagnostic preparations for clinical or medical laboratory use
Class 9
diagnostic apparatus and instrumentsnot for medical purposesfor staining and visualisation of tissue or cell based samples for research and scientific use; laboratory apparatus for detection of tissue and/or cell based samples not for medical purposes; recorded and downloadable software for identifying and diagnosing cancer and other diseases and processing digital images; analysis apparatus for laboratory use for analyzing the results of tissues and cell based samples obtained through operation of tissue and cell sample staining apparatus not for medical purposes; diagnostic measuring apparatus used to identify and/or diagnose cancer and other diseasesnot for medical use; diagnostic laboratory testing apparatus incorporating chemical reagents for analysing the results of tissues and cell based samplesnot for medical use
Class 10
Diagnostic apparatus and instruments for medical use for staining and/or visualization of tissue or cell based samples for diagnostic or medical use for pathology purposespathological assessmentpathological testingperforming immunohistochemistry and in situ-hybridisation staining reactionshistological and pathological staining; diagnostic apparatus for detection of tissue and/or cell based samplesall for medical purposes for pathology purposespathological assessmentpathological testingperforming immunohistochemistry and in situ-hybridisation staining reactionshistological and pathological staining; medical analysis and medical measuring apparatusnamely medical diagnostic instruments for the analysis of body fluids and tissue for medical diagnostic uses; medical apparatus and instruments for pathology purposesfor pathological assessmentpathological testingperforming immunohistochemistry and in situ-hybridisation staining reactionshistological and pathological staining; apparatus for use in medical analysismedical diagnostic apparatus for pathology purposespathological assessmentpathological testingperforming immunohistochemistry and in situ-hybridisation staining reactionshistological and pathological staining; testing apparatus for medical purposeshistopathology instrumentshaematology instrumentsboth for clinical purposesfor pathology purposespathological assessmentpathological testingperforming immunohistochemistry and in situ-hybridisation staining reactionshistological and pathological staining; diagnostic medical apparatus namelyhistopathology instrumentshaematology instrumentsboth for clinical purposesfor pathology purposespathological assessmentpathological testingperforming immunohistochemistry and in situ-hybridisation staining reactionshistological and pathological stainingfor promoting and controlling reaction on microarrays or under slide covertiles; in-vitro diagnostic testing apparatus incorporating chemical reagents for medical use; medical specimen collection slides for specimen collection in surgery
Class 42
Medical research; installation and integration of softwareincluding within existing hospital and laboratory infrastructure; maintenanceservicingupdating and upgrading of software; all the aforementioned for use in connection with medical analysisdiagnosis and research
Publications
History of USPTO decisions and trademark events.
38 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/26/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
05/26/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/07/2026
PUBO
PUBLISHED FOR OPPOSITION
04/07/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/01/2026
EXPT
EXPARTE APPEAL TERMINATED
03/16/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/16/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
03/16/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/16/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
03/16/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/16/2026
EXPI
EX PARTE APPEAL-INSTITUTED
03/04/2026
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
03/04/2026
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
03/04/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/03/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/03/2026
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/03/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/05/2025
GNFR
FINAL REFUSAL E-MAILED
09/05/2025
CNFR
FINAL REFUSAL WRITTEN
09/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2025
RFNT
REFUSAL PROCESSED BY IB
03/22/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/04/2025
RFRR
REFUSAL PROCESSED BY MPU
03/04/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/01/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/01/2025
CNRT
NON-FINAL ACTION WRITTEN
02/28/2025
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
02/26/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/12/2025
CNRT
NON-FINAL ACTION WRITTEN
04/29/2024
DOCK
ASSIGNED TO EXAMINER
04/17/2024
MAFR
APPLICATION FILING RECEIPT MAILED
09/19/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/14/2023
Continuous trademark protection
Get notified about every new filing that threatens BOND PRIME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.